Skip to main content
Caplight Logo









Pinwheel Therapeutics

Pinwheel Therapeutics

Private
ConnecticutHealthcare & Life Scienceshttps://pinwheeltherapeutics.com

Last Round

Series A

Feb 4, 2026

Total Funding Raised

$20M

Company Overview

Pinwheel Therapeutics is a biotechnology company that develops clinical-stage anticoagulant reversal therapies for emergency medical settings.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

anticoagulant reversalciraparantagblood thinner reversalbiopharmaceuticalacute-care medicineemergency medicinesmall molecule therapyclinical-stage biotechtrauma careintracranial hemorrhageFactor Xa inhibitorthrombin inhibitorclinical trialsdrug developmentbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pinwheel Therapeutics Comparables

Compare Pinwheel Therapeutics with similar companies based on industry and business-model similarity.

Pinwheel Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alveron Pharma
83%
SERB
77%
AstraZeneca
74%

Pinwheel Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 4, 2026

Pinwheel Therapeutics Investors

Notable investors and investment history

Pinwheel Therapeutics investors
InvestorRounds
Claypond CapitalSeries A
108 BioCapitalSeries A

Pinwheel Therapeutics Filings

Explore SEC and related filing metadata, where available.

Pinwheel Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pinwheel Therapeutics's valuation, stock price, and market status.

Is Pinwheel Therapeutics a public or private company?

Pinwheel Therapeutics is a private company.

What is the current stock price of Pinwheel Therapeutics?

Pinwheel Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Pinwheel Therapeutics worth (valuation)?

Valuation information for Pinwheel Therapeutics is not publicly available.

Can I buy Pinwheel Therapeutics stock?

Pinwheel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pinwheel Therapeutics's last funding round?

Pinwheel Therapeutics's most recent funding round was Series A on February 4, 2026.

Who are the main investors in Pinwheel Therapeutics?

Key investors in Pinwheel Therapeutics include 108 BioCapital.

Will Pinwheel Therapeutics IPO soon?

No public IPO plans have been announced for Pinwheel Therapeutics.

How can I track Pinwheel Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pinwheel Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersConnecticut
Year FoundedN/A
Last FundingFeb 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?